These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1294722)

  • 1. [Contrast media in hepatic MRI].
    Grellet J; Bellin MF; Dion E
    J Radiol; 1992 Oct; 73(10):495-9. PubMed ID: 1294722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver MRI with contrast enhancement.
    Runge VM
    Crit Rev Diagn Imaging; 1997 Jun; 38(3):207-30. PubMed ID: 9226107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current uses of gadolinium chelates for clinical magnetic resonance imaging examination of the liver.
    Low RN
    Top Magn Reson Imaging; 1998 Jun; 9(3):141-66. PubMed ID: 9621404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Status and development of new clinical contrast media for MR diagnosis of liver diseases].
    Rummeny EJ; Peters PE
    Radiologe; 1992 May; 32(5):225-31. PubMed ID: 1635982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR imaging of the liver. Contrast agents.
    Mahfouz AE; Hamm B
    Magn Reson Imaging Clin N Am; 1997 May; 5(2):223-40. PubMed ID: 9113673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted contrast agents in MR imaging.
    Gupta H; Weissleder R
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):171-84. PubMed ID: 8673713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR imaging of the liver using gadolinium chelates.
    Low RN
    Magn Reson Imaging Clin N Am; 2001 Nov; 9(4):717-43, vi. PubMed ID: 11694435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gadolinium-enhanced MR imaging of liver capsule and peritoneum.
    Low RN
    Magn Reson Imaging Clin N Am; 2001 Nov; 9(4):803-19, vii. PubMed ID: 11694439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced liver MR: contrast agents and imaging strategy.
    Runge VM; Kirsch JE; Wells JW; Awh MH; Bittner DF; Woolfolk CE
    Crit Rev Diagn Imaging; 1993; 34(1-2):1-30. PubMed ID: 8216813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast agents for MR imaging of the liver.
    Balci NC; Semelka RC
    Radiol Clin North Am; 2005 Sep; 43(5):887-98, viii. PubMed ID: 16098345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced magnetic resonance imaging of the abdomen.
    Brown ED; Semelka RC
    Magn Reson Q; 1994 Jun; 10(2):97-124. PubMed ID: 7986704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of an asialoglycoprotein receptor-targeted magnetic resonance contrast agent to study changes in receptor biology during liver regeneration and endotoxemia in rats.
    Leveille-Webster CR; Rogers J; Arias IM
    Hepatology; 1996 Jun; 23(6):1631-41. PubMed ID: 8675187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Iron oxides as contrast agents for MRI of the liver].
    Van Beers BE; Pringot J; Gallez B
    J Radiol; 1995 Nov; 76(11):991-5. PubMed ID: 8594187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR contrast agents, the old and the new.
    Bellin MF
    Eur J Radiol; 2006 Dec; 60(3):314-23. PubMed ID: 17005349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging of the liver.
    Larson RE; Semelka RC
    Top Magn Reson Imaging; 1995; 7(2):71-81. PubMed ID: 7772372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization.
    Kubaska S; Sahani DV; Saini S; Hahn PF; Halpern E
    Clin Radiol; 2001 May; 56(5):410-5. PubMed ID: 11384141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
    Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should Gd chelates be used routinely for liver MR imaging?
    Saini S
    AJR Am J Roentgenol; 1995 Jun; 164(6):1550. PubMed ID: 7754917
    [No Abstract]   [Full Text] [Related]  

  • 19. [Magnetic resonance tomography in focal diseases of the liver (review)].
    Kholin AV
    Vestn Rentgenol Radiol; 1990; (2):59-63. PubMed ID: 2219689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo evaluation of gadolinium hydroxypyridonate chelates: initial experience as contrast media in magnetic resonance imaging.
    Thompson MK; Misselwitz B; Tso LS; Doble DM; Schmitt-Willich H; Raymond KN
    J Med Chem; 2005 Jun; 48(11):3874-7. PubMed ID: 15916439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.